-
Entity
-
Individual
-
Location
-
C/O Achillion Pharmaceuticals, Inc., 300 George Street, New Haven, CT
-
Summary
-
The estimated net worth of Robert L. Van Nostrand is at least $856K dollars as of July 2, 2024. Robert L. Van Nostrand is the Director of Intra-Cellular Therapies, Inc. and owns shares of Intra-Cellular Therapies, Inc. (ITCI) stock worth about $777K. Robert L. Van Nostrand is the Director of SELLAS Life Sciences Group, Inc. and owns shares of SELLAS Life Sciences Group, Inc. (SLS) stock worth about $65K. Robert L. Van Nostrand is the Director of YIELD10 BIOSCIENCE, INC. and owns shares of YIELD10 BIOSCIENCE, INC. (YTEN) stock worth about $14.6K.